Published Guidance, NICE advice and quality standards
Showing 1 to 3 of 3
Title | Reference number | Published | Last updated |
---|---|---|---|
Ustekinumab for treating active psoriatic arthritis | TA340 | ||
Apremilast for treating active psoriatic arthritis | TA433 | ||
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | TA415 |